Artificial Intelligence In Drug Discovery Market (2026 - 2033) Size, Share & Trends Analysis Report By Application (Drug Optimization and Repurposing, Preclinical Testing), By Therapeutic Area (Oncology, Neurodegenerative Disease), By End Use, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Market Definitions
                        1.2.1. Application Segment
                        1.2.2. Therapeutic Area
                        1.2.3. End Use
                    1.3. Information analysis
                        1.3.1. Market formulation & data visualization
                    1.4. Data validation & publishing
                    1.5. Information Procurement
                        1.5.1. Primary Research
                    1.6. Information or Data Analysis
                    1.7. Market Formulation & Validation
                    1.8. Market Model
                    1.9. Total Market: CAGR Calculation
                    1.10. Objectives
                        1.10.1. Objective 1
                        1.10.2. Objective 2
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Insights Landscape
Chapter 3. Artificial Intelligence in Drug Discovery Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook.
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Rising demand for cost-effective drug development
                            3.2.1.2. Increasing clinical trials in drug repurposing
                            3.2.1.3. Growing focus on precision medicine and targeted drug development
                        3.2.2. Market restraint analysis
                            3.2.2.1. Highly regulated industry
                            3.2.2.2. High computational costs and infrastructure requirements
                        3.2.3. Market opportunity analysis
                        3.2.4. Market challenges analysis
                    3.3. Case Study Insights
                    3.4. Artificial Intelligence in Drug Discovery Market Analysis Tools
                        3.4.1. Industry Analysis - Porter’s
                            3.4.1.1. Supplier power
                            3.4.1.2. Buyer power
                            3.4.1.3. Substitution threat
                            3.4.1.4. Threat of new entrant
                            3.4.1.5. Competitive rivalry
                        3.4.2. PESTEL Analysis
                            3.4.2.1. Political landscape
                            3.4.2.2. Technological landscape
                            3.4.2.3. Economic landscape
                            3.4.2.4. Environmental Landscape
                            3.4.2.5. Legal Landscape
                            3.4.2.6. Social Landscape
Chapter 4. Artificial Intelligence in Drug Discovery Market: Application Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Global Artificial Intelligence in Drug Discovery Market Application Movement Analysis
                    4.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
                    4.4. Drug optimization and repurposing
                        4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
                    4.5. Preclinical testing
                        4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
                    4.6. Others
                        4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. Artificial Intelligence in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Global Artificial Intelligence in Drug Discovery Market Therapeutic Area Movement Analysis
                    5.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Million)
                    5.4. Oncology
                        5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
                    5.5. Neurodegenerative Diseases
                        5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
                    5.6. Cardiovascular Disease
                        5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
                    5.7. Metabolic Diseases
                        5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
                    5.8. Infectious Disease
                        5.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
                    5.9. Others
                        5.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 6. Artificial Intelligence in Drug Discovery Market: End Use Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Global Artificial Intelligence in Drug Discovery Market End Use Movement Analysis
                    6.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
                    6.4. Pharmaceutical & Biotechnology Companies
                        6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
                    6.5. Contract Research Organizations (CROs)
                        6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
                    6.6. Academic and Research Institutes
                        6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
                    6.7. Other
                        6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 7. Artificial Intelligence in Drug Discovery Market: Regional Estimates & Trend Analysis
                    7.1. Regional Market Share Analysis, 2025 & 2033
                    7.2. Regional Market Dashboard
                    7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
                    7.4. North America
                        7.4.1. U.S.
                            7.4.1.1. Key country dynamics
                            7.4.1.2. Regulatory framework
                            7.4.1.3. Competitive scenario
                            7.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.4.2. Canada
                            7.4.2.1. Key country dynamics
                            7.4.2.2. Regulatory framework
                            7.4.2.3. Competitive scenario
                            7.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.4.3. Mexico
                            7.4.3.1. Key country dynamics
                            7.4.3.2. Regulatory framework
                            7.4.3.3. Competitive scenario
                            7.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
                    7.5. Europe
                        7.5.1. UK
                            7.5.1.1. Key country dynamics
                            7.5.1.2. Regulatory framework
                            7.5.1.3. Competitive scenario
                            7.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.5.2. Germany
                            7.5.2.1. Key country dynamics
                            7.5.2.2. Regulatory framework
                            7.5.2.3. Competitive scenario
                            7.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.5.3. France
                            7.5.3.1. Key country dynamics
                            7.5.3.2. Regulatory framework
                            7.5.3.3. Competitive scenario
                            7.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.5.4. Italy
                            7.5.4.1. Key country dynamics
                            7.5.4.2. Regulatory framework
                            7.5.4.3. Competitive scenario
                            7.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.5.5. Spain
                            7.5.5.1. Key country dynamics
                            7.5.5.2. Regulatory framework
                            7.5.5.3. Competitive scenario
                            7.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.5.6. Norway
                            7.5.6.1. Key country dynamics
                            7.5.6.2. Regulatory framework
                            7.5.6.3. Competitive scenario
                            7.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.5.7. Sweden
                            7.5.7.1. Key country dynamics
                            7.5.7.2. Regulatory framework
                            7.5.7.3. Competitive scenario
                            7.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.5.8. Denmark
                            7.5.8.1. Key country dynamics
                            7.5.8.2. Regulatory framework
                            7.5.8.3. Competitive scenario
                            7.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
                    7.6. Asia Pacific
                        7.6.1. Japan
                            7.6.1.1. Key country dynamics
                            7.6.1.2. Regulatory framework
                            7.6.1.3. Competitive scenario
                            7.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.6.2. China
                            7.6.2.1. Key country dynamics
                            7.6.2.2. Regulatory framework
                            7.6.2.3. Competitive scenario
                            7.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.6.3. India
                            7.6.3.1. Key country dynamics
                            7.6.3.2. Regulatory framework
                            7.6.3.3. Competitive scenario
                            7.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.6.4. Australia
                            7.6.4.1. Key country dynamics
                            7.6.4.2. Regulatory framework
                            7.6.4.3. Competitive scenario
                            7.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.6.5. South Korea
                            7.6.5.1. Key country dynamics
                            7.6.5.2. Regulatory framework
                            7.6.5.3. Competitive scenario
                            7.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.6.6. Thailand
                            7.6.6.1. Key country dynamics
                            7.6.6.2. Regulatory framework
                            7.6.6.3. Competitive scenario
                            7.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
                    7.7. Latin America
                        7.7.1. Brazil
                            7.7.1.1. Key country dynamics
                            7.7.1.2. Regulatory framework
                            7.7.1.3. Competitive scenario
                            7.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.7.2. Argentina
                            7.7.2.1. Key country dynamics
                            7.7.2.2. Regulatory framework
                            7.7.2.3. Competitive scenario
                            7.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
                    7.8. MEA
                        7.8.1. South Africa
                            7.8.1.1. Key country dynamics
                            7.8.1.2. Regulatory framework
                            7.8.1.3. Competitive scenario
                            7.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.8.2. Saudi Arabia
                            7.8.2.1. Key country dynamics
                            7.8.2.2. Regulatory framework
                            7.8.2.3. Competitive scenario
                            7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.8.3. UAE
                            7.8.3.1. Key country dynamics
                            7.8.3.2. Regulatory framework
                            7.8.3.3. Competitive scenario
                            7.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
                        7.8.4. Kuwait
                            7.8.4.1. Key country dynamics
                            7.8.4.2. Regulatory framework
                            7.8.4.3. Competitive scenario
                            7.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Company/Competition Categorization
                    8.2. Strategy Mapping
                    8.3. Company Market Position Analysis, 2025
                    8.4. Company Profiles/Listing
                        8.4.1. Healx
                            8.4.1.1. Company overview
                            8.4.1.2. Financial performance
                            8.4.1.3. Product benchmarking
                            8.4.1.4. Strategic initiatives
                        8.4.2. BostonGene Corporation
                            8.4.2.1. Company overview
                            8.4.2.2. Financial performance
                            8.4.2.3. Product benchmarking
                            8.4.2.4. Strategic initiatives
                        8.4.3. BenevolentAI
                            8.4.3.1. Company overview
                            8.4.3.2. Financial performance
                            8.4.3.3. Product benchmarking
                            8.4.3.4. Strategic initiatives
                        8.4.4. Innophore
                            8.4.4.1. Company overview
                            8.4.4.2. Financial performance
                            8.4.4.3. Product benchmarking
                            8.4.4.4. Strategic initiatives
                        8.4.5. Delta4.ai
                            8.4.5.1. Company overview
                            8.4.5.2. Financial performance
                            8.4.5.3. Product benchmarking
                            8.4.5.4. Strategic initiatives
                        8.4.6. BioXcel Therapeutics Inc.
                            8.4.6.1. Company overview
                            8.4.6.2. Financial performance
                            8.4.6.3. Product benchmarking
                            8.4.6.4. Strategic initiatives
                        8.4.7. BullFrog AI Holdings, Inc.
                            8.4.7.1. Company overview
                            8.4.7.2. Financial performance
                            8.4.7.3. Product benchmarking
                            8.4.7.4. Strategic initiatives
                        8.4.8. Graphwise
                            8.4.8.1. Company overview
                            8.4.8.2. Financial performance
                            8.4.8.3. Product benchmarking
                            8.4.8.4. Strategic initiatives
                        8.4.9. Owkin, Inc
                            8.4.9.1. Company overview
                            8.4.9.2. Financial performance
                            8.4.9.3. Product benchmarking
                            8.4.9.4. Strategic initiatives
                        8.4.10. Insilico Medicine
                            8.4.10.1. Company overview
                            8.4.10.2. Financial performance
                            8.4.10.3. Product benchmarking
                            8.4.10.4. Strategic initiatives
                        8.4.11. IBM
                            8.4.11.1. Company overview
                            8.4.11.2. Financial performance
                            8.4.11.3. Product benchmarking
                            8.4.11.4. Strategic initiatives
                        8.4.12. Exscientia
                            8.4.12.1. Company overview
                            8.4.12.2. Financial performance
                            8.4.12.3. Product benchmarking
                            8.4.12.4. Strategic initiatives
                        8.4.13. Google (DeepMind)
                            8.4.13.1. Company overview
                            8.4.13.2. Financial performance
                            8.4.13.3. Product benchmarking
                            8.4.13.4. Strategic initiatives
                        8.4.14. BioSymetrics, Inc.
                            8.4.14.1. Company overview
                            8.4.14.2. Financial performance
                            8.4.14.3. Product benchmarking
                            8.4.14.4. Strategic initiatives
                        8.4.15. BPGbio Inc. (Berg Health)
                            8.4.15.1. Company overview
                            8.4.15.2. Financial performance
                            8.4.15.3. Product benchmarking
                            8.4.15.4. Strategic initiatives
                        8.4.16. Atomwise Inc.
                            8.4.16.1. Company overview
                            8.4.16.2. Financial performance
                            8.4.16.3. Product benchmarking
                            8.4.16.4. Strategic initiatives
                        8.4.17. Recursion
                            8.4.17.1. Company overview
                            8.4.17.2. Financial performance
                            8.4.17.3. Product benchmarking
                            8.4.17.4. Strategic initiatives
                        8.4.18. Aitia
                            8.4.18.1. Company overview
                            8.4.18.2. Financial performance
                            8.4.18.3. Product benchmarking
                            8.4.18.4. Strategic initiatives
                        8.4.19. Insitro
                            8.4.19.1. Company overview
                            8.4.19.2. Financial performance
                            8.4.19.3. Product benchmarking
                            8.4.19.4. Strategic initiatives

List of Tables

Table 1 List Of Abbreviations
Table 2 Global Artificial Intelligence In Drug Discovery Market, By Region, 2021 - 2033 (USD Million)
Table 3 Global Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 4 Global Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 5 Global Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 6 North America Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
Table 7 North America Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 8 North America Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 9 North America Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 10 US Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 11 US Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 12 US Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 13 Canada Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 14 Canada Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 15 Canada Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 16 Mexico Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 17 Mexico Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 18 Mexico Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 19 Europe Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
Table 20 Europe Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 21 Europe Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 22 Europe Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 23 UK Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 24 UK Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 25 UK Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 26 Germany Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 27 Germany Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 28 Germany Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 29 France Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 30 France Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 31 France Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 32 Italy Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 33 Italy Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 34 Italy Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 35 Spain Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 36 Spain Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 37 Spain Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 38 Denmark Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 39 Denmark Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 40 Denmark Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 41 Sweden Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 42 Sweden Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 43 Sweden Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 44 Norway Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 45 Norway Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 46 Norway Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 47 Asia Pacific Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
Table 48 Asia Pacific Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 49 Asia Pacific Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 50 Asia Pacific Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 51 China Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 52 China Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 53 China Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 54 Japan Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 55 Japan Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 56 Japan Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 57 India Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 58 India Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 59 India Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 60 South Korea Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 61 South Korea Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 62 South Korea Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 63 Australia Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 64 Australia Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 65 Australia Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 66 Thailand Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 67 Thailand Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 68 Thailand Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 69 Latin America Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
Table 70 Latin America Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 71 Latin America Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 72 Latin America Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 73 Brazil Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 74 Brazil Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 75 Brazil Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 76 Argentina Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 77 Argentina Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 78 Argentina Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 79 MEA Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
Table 80 MEA Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 81 MEA Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 82 MEA Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 83 South Africa Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 84 South Africa Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 85 South Africa Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 86 Saudi Arabia Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 87 Saudi Arabia Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 88 Saudi Arabia Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 89 UAE Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 90 UAE Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 91 UAE Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
Table 92 Kuwait Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
Table 93 Kuwait Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 94 Kuwait Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Market formulation & validation
Fig. 5 Artificial intelligence in drug discovery market: Market outlook
Fig. 6 Artificial intelligence in drug discovery market: Segment outlook
Fig. 7 Artificial intelligence in drug discovery market: Competitive landscape outlook
Fig. 8 Parent market outlook
Fig. 9 Artificial intelligence in drug discovery market driver impact
Fig. 10 Artificial intelligence in drug discovery market restraint impact
Fig. 11 Artificial intelligence in drug discovery market: Application outlook and key takeaways
Fig. 12 Artificial intelligence in drug discovery market: Application movement analysis
Fig. 13 Drug optimization and repurposing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 14 Preclinical testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 15 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 16 Computer vision market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 17 Artificial intelligence in drug discovery market: Therapeutic Area outlook and key takeaways
Fig. 18 Artificial intelligence in drug discovery market: Therapeutic Area movement analysis
Fig. 19 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 20 Neurodegenerative diseases market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 Cardiovascular disease market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Metabolic diseases market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 Infectious disease market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 Artificial intelligence in drug discovery market: End use outlook and key takeaways
Fig. 26 Artificial intelligence in drug discovery market: End use movement analysis
Fig. 27 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Contract research organizations (CROs) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Global Artificial intelligence in drug discovery market: Regional outlook and key takeaways
Fig. 32 Global Artificial intelligence in drug discovery market: Regional movement analysis
Fig. 33 North America market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 US key country dynamics
Fig. 35 US market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Canada key country dynamics
Fig. 37 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 Mexico key country dynamics
Fig. 39 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 40 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 UK key country dynamics
Fig. 42 UK market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Germany key country dynamics
Fig. 44 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 45 France key country dynamics
Fig. 46 France market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 Italy key country dynamics
Fig. 48 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 49 Spain key country dynamics
Fig. 50 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 51 Denmark key country dynamics
Fig. 52 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 53 Sweden key country dynamics
Fig. 54 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 55 Norway key country dynamics
Fig. 56 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 57 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 58 Japan key country dynamics
Fig. 59 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 60 China key country dynamics
Fig. 61 China market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 62 India key country dynamics
Fig. 63 India market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 64 Thailand key country dynamics
Fig. 65 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 66 South Korea key country dynamics
Fig. 67 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 68 Australia key country dynamics
Fig. 69 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 70 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 71 Brazil key country dynamics
Fig. 72 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 73 Argentina key country dynamics
Fig. 74 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 75 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 76 South Africa key country dynamics
Fig. 77 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 78 Saudi Arabia key country dynamics
Fig. 79 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 80 UAE key country dynamics
Fig. 81 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 82 Kuwait key country dynamics
Fig. 83 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)